GEO and TCGA RNA-seq expression datasets were used to evaluate the mRNA expression of RPL22L1, results showed it was significantly higher in GBM and oligodendroglioma tissues than that in normal brain tissues (Fig. 1A, B). This evidence concerns the gene RPL22L1 and glioblastoma.